Zobrazeno 1 - 10
of 13
pro vyhledávání: '"M. A. Esteban-Moreno"'
Autor:
Jesús Rodríguez-Baño, Antonio Luque-Pineda, Julian Torre-Cisneros, M Ángeles Esteban-Moreno, Rafael León López, Sheila Cárcel Fernández, Laura Limia Pérez, Alberto Romero Palacios, María Concepción Fernández-Roldán, Eduardo Aguilar Alonso, Inés Pérez Camacho, Nicolás Merchante, Julián Olalla, Marta Santos
Publikováno v:
BMJ Open, Vol 10, Iss 11 (2020)
Introduction About 25% of patients with COVID-19 develop acute respiratory distress syndrome (ARDS) associated with a high release of pro-inflammatory cytokines such as interleukin-6 (IL-6). The aim of the SARICOR study is to demonstrate that early a
Externí odkaz:
https://doaj.org/article/163f0988921e4d2b87b1245e7cc548b1
Autor:
Jesús Rodríguez-Baño, Zaira R Palacios-Baena, Clara M Rosso-Fernández, Pilar Retamar, Lucia Valiente de Santis, Natalia Maldonado, Irene Borreguero, Carmen Herrero-Rodríguez, Salvador López-Cárdenas, Franciso J Martínez-Marcos, Andrés Martín-Aspas, Patricia Jiménez-Aguilar, Juan J Castón, Guillermo Ojeda-Burgos, M Pilar Aznarte-Padial, Julia Praena-Segovia, Juan E Corzo-Delgado, M Ángeles Esteban-Moreno
Publikováno v:
BMJ Open, Vol 10, Iss 7 (2020)
Introduction Ceftaroline, tedizolid, dalbavancin, ceftazidime-avibactam and ceftolozane-tazobactam are novel antibiotics used to treat infections caused by multidrug-resistant pathogens (MDR). Their use should be supervised and monitored as part of a
Externí odkaz:
https://doaj.org/article/ae4b720c1c1146fc8c5b50b1c0e6de45
Autor:
Laura Perez, María Concepción Fernández-Roldán, Antonio Luque-Pineda, Julián Torre-Cisneros, M Ángeles Esteban-Moreno, Inés Pérez Camacho, Marta Santos, Alberto Romero Palacios, Rafael León López, Julián Olalla, Jesús Rodríguez-Baño, Nicolás Merchante, Eduardo Aguilar Alonso, Sheila Cárcel Fernández
Publikováno v:
BMJ Open, Vol 10, Iss 11 (2020)
Digital.CSIC. Repositorio Institucional del CSIC
instname
BMJ Open
Digital.CSIC. Repositorio Institucional del CSIC
instname
BMJ Open
[Introduction] About 25% of patients with COVID-19 develop acute respiratory distress syndrome (ARDS) associated with a high release of pro-inflammatory cytokines such as interleukin-6 (IL-6). The aim of the SARICOR study is to demonstrate that early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c0bbbf1f7dbaaec58e71590ad201cc9
https://bmjopen.bmj.com/content/10/11/e039951.full
https://bmjopen.bmj.com/content/10/11/e039951.full
Autor:
Pilar Retamar, Carmen Herrero-Rodríguez, Lucia Valiente de Santis, Natalia Maldonado, Patricia Jiménez-Aguilar, M Ángeles Esteban-Moreno, M Pilar Aznarte-Padial, Andrés Martín-Aspas, Francisco Anguita-Santos, Clara M Rosso-Fernández, Zaira R. Palacios-Baena, Juan José Castón, Jesús Rodríguez-Baño, Juan Enrique Corzo-Delgado, Salvador López-Cárdenas, Guillermo Ojeda-Burgos, Franciso J Martínez-Marcos, Julia Praena-Segovia, Irene Borreguero Borreguero
Publikováno v:
BMJ Open, Vol 10, Iss 7 (2020)
BMJ Open 2020;10:e035460
RODIN: Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Universidad de Cádiz
BMJ Open
Digital.CSIC. Repositorio Institucional del CSIC
instname
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
BMJ Open 2020;10:e035460
RODIN: Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Universidad de Cádiz
BMJ Open
Digital.CSIC. Repositorio Institucional del CSIC
instname
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
[Introduction] Ceftaroline, tedizolid, dalbavancin, ceftazidime-avibactam and ceftolozane-tazobactam are novel antibiotics used to treat infections caused by multidrug-resistant pathogens (MDR). Their use should be supervised and monitored as part of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d91c756dd770725e56062ca163d938b
https://bmjopen.bmj.com/content/10/7/e035460.full
https://bmjopen.bmj.com/content/10/7/e035460.full
Publikováno v:
Journal of Hypertension. 29:e531
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b06bbf88f3d4b928659d7610b0364d3
https://doi.org/10.1097/00004872-201106001-01607
https://doi.org/10.1097/00004872-201106001-01607
Publikováno v:
Journal of Hypertension. 29:e182
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fe50293a35e2b25e4c98d534b2d0074
https://doi.org/10.1097/00004872-201106001-00481
https://doi.org/10.1097/00004872-201106001-00481
Publikováno v:
Journal of Hypertension. 29:e157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09c31455de8b58291ec19be8a0da23a5
https://doi.org/10.1097/00004872-201106001-00398
https://doi.org/10.1097/00004872-201106001-00398
Publikováno v:
Mycoses. Oct2002, Vol. 45 Issue 7/8, p317-328. 12p.
Autor:
Palacio, Amalia, Cuétara, S., Izquierdo, I., Videla, S., Delgadillo, J., Boncompte, E., Noriega, A. Rodríguez
Publikováno v:
Mycoses; Sep1995, Vol. 38 Issue 9/10, p395-403, 9p
Autor:
Poveda-García, M. I., Esteban-Moreno, M. A., González-Martínez, F. J., Del Pino Y. Pino, M. D.
Publikováno v:
Journal of Hypertension; 2011 Jun Suppl A, Vol. 29, pe531-e531, 1p